Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Isn’t part of the reason why GLP-1 drugs work so well, is because they do something that interferes with that “food drive”? I think it’s different than gastric bypass in that way
I think is the other way around. They extend the “I’m fullfil” hormone like from minutes to hours, so people don’t find themselves snacking an hour after eating
Yes, but the problem is that these are not meant to be forever drugs. You’re supposed to take them in conjunction with changing diet and exercise habits so that you can go off the drug and maintain a healthy weight on your own. Often people get off of these drugs without having done the work, and they end up right back where they started.